Terms: = Cervical cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Diagnosis
21 results:
1.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract] [Full Text] [Related]
2. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
Kashofer K; Regauer S; Reich O; Petru E; Winter E
Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
[TBL] [Abstract] [Full Text] [Related]
3. Morphological Based Medical Image Processing on cervical Cytology cancer Images Using Connected Component Techniques.
Robert P; Kavida AC
Curr Med Imaging; 2021; 17(12):1439-1450. PubMed ID: 34238167
[TBL] [Abstract] [Full Text] [Related]
4. Downregulation of 5-hydroxymethylcytosine is associated with the progression of cervical intraepithelial neoplasia.
Kato M; Onoyama I; Kawakami M; Yoshida S; Kawamura K; Kodama K; Hori E; Cui L; Matsumura Y; Yagi H; Asanoma K; Yahata H; Itakura A; Takeda S; Kato K
PLoS One; 2020; 15(11):e0241482. PubMed ID: 33141854
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of NCC-RbC-51, an RB cell line isolated from a metastatic site.
Ravishankar H; Mangani AS; Shankar MB; Joshi M; Devasena T; Parameswaran S; Subramaniam K
Histochem Cell Biol; 2020 Feb; 153(2):101-109. PubMed ID: 31781967
[TBL] [Abstract] [Full Text] [Related]
6. Expression Analysis of RbBP6 in human cancers: a Prospective biomarker.
Mbita Z; Hull R; Mbele M; Makhafola T; Dlamini Z
Anticancer Drugs; 2019 Sep; 30(8):767-773. PubMed ID: 31274515
[TBL] [Abstract] [Full Text] [Related]
7. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.
Jo VY; Krane JF; Pantanowitz L; Monaco SE
Cancer Cytopathol; 2019 Feb; 127(1):26-34. PubMed ID: 30475447
[TBL] [Abstract] [Full Text] [Related]
8. Potential Diagnostic Pitfalls in Evaluating Immunohistochemistry for cervical Myofibroblastomas.
Song S; Ziober A; Cooper K
Int J Gynecol Pathol; 2019 Nov; 38(6):597-601. PubMed ID: 30383612
[TBL] [Abstract] [Full Text] [Related]
9. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
[TBL] [Abstract] [Full Text] [Related]
10. Downregulation of p16(ink4a) inhibits cell proliferation and induces G1 cell cycle arrest in cervical cancer cells.
Zhang CY; Bao W; Wang LH
Int J Mol Med; 2014 Jun; 33(6):1577-85. PubMed ID: 24714974
[TBL] [Abstract] [Full Text] [Related]
11. HPV and cervical cancer: updates on an established relationship.
Subramanya D; Grivas PD
Postgrad Med; 2008 Nov; 120(4):7-13. PubMed ID: 19020360
[TBL] [Abstract] [Full Text] [Related]
12. Molecular approaches to cervical cancer therapy.
Alvarez-Salas LM; DiPaolo JA
Curr Drug Discov Technol; 2007 Oct; 4(3):208-19. PubMed ID: 17986003
[TBL] [Abstract] [Full Text] [Related]
13. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.
Looi K; Megliorino R; Shi FD; Peng XX; Chen Y; Zhang JY
Oncol Rep; 2006 Nov; 16(5):1105-10. PubMed ID: 17016600
[TBL] [Abstract] [Full Text] [Related]
14. p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome.
Branca M; Ciotti M; Santini D; Di Bonito L; Giorgi C; Benedetto A; Paba P; Favalli C; Costa S; Agarossi A; Alderisio M; Syrjänen K
Int J Gynecol Pathol; 2004 Oct; 23(4):354-65. PubMed ID: 15381905
[TBL] [Abstract] [Full Text] [Related]
15. HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene.
do Horto dos Santos Oliveira L; Rodrigues Ede V; de Salles Lopes AP; Fernandez Ade P; Cavalcanti SM
Sao Paulo Med J; 2003 Mar; 121(2):67-71. PubMed ID: 12870053
[TBL] [Abstract] [Full Text] [Related]
16. The role of tumour suppressors and viral oncoproteins in cervical carcinogenesis.
Anton M; Horký M; Bláha O
Ceska Gynekol; 2000 Jul; 65(4):275-8. PubMed ID: 11039236
[TBL] [Abstract] [Full Text] [Related]
17. [Cervico-uterine cancer. Influence of cell and viral genes. Implications in the development of vaccines].
Gariglio P
Gac Med Mex; 1998; 134(3):297-307; discussion 309-10. PubMed ID: 9780490
[TBL] [Abstract] [Full Text] [Related]
18. Polymorphous low-grade adenocarcinoma of minor salivary glands: a study of 17 cases with emphasis on cell differentiation.
Perez-Ordonez B; Linkov I; Huvos AG
Histopathology; 1998 Jun; 32(6):521-9. PubMed ID: 9675591
[TBL] [Abstract] [Full Text] [Related]
19. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer.
Amortegui AJ; Meyer MP; Elborne VL; Amin RM
Mod Pathol; 1995 Dec; 8(9):907-12. PubMed ID: 8751330
[TBL] [Abstract] [Full Text] [Related]
20. Multistep carcinogenesis and genital papillomavirus infection. Implications for diagnosis and vaccines.
Rangel LM; Ramírez M; Torroella M; Pedroza A; Ibarra V; Gariglio P
Arch Med Res; 1994; 25(2):265-72. PubMed ID: 7919824
[TBL] [Abstract] [Full Text] [Related]
[Next]